Sunday 15 July 2018
Contact US    |    Archive
cnbc.com
3 months ago

Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more

The medicines, which help unleash the immune system on cancer cells, were tested in patients with advanced lung cancer.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

Merck

 | 

Bristol

 | 

Myers

 | 

cancer

 | 

drugs

 | 

both

 | 

beat

 | 

expectations

 | 

but

 | 

Merck

 | 

beats

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
USA